SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM Statement

10 Feb 2016 07:00

RNS Number : 5837O
Victrex PLC
10 February 2016
 
 

 

 

 

10 February 2016

Victrex plc

AGM and Q1 Interim Management Statement

'Soft Q1; expectation of a stronger H2 underpins full year'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first quarter (Q1) Interim Management Statement ahead of its Annual General Meeting today.

Pleasingly, the overall performance in our industrial markets outside of Oil & Gas and Electronics was solid. Invibio also showed a small improvement compared to Q1 2015. Whilst Q1 2016 was softer compared to Q1 2015, this reflects the expected lower volumes in Consumer Electronics and Oil & Gas, where the prior period comparatives are tougher and a worsening environment in that market since our 2015 preliminary results.

At a revenue and volume level, Q1 Group revenue of £56.0m was 6% down on the prior year (Q1 2015: £59.8m), with Group sales volume of 860 tonnes being 11% down on the prior year (Q1 2015: 967 tonnes).

Based on the outlook for Oil & Gas and lower Consumer Electronics volumes, we expect this softness to continue through the first half year. Compared to previous guidance, volumes from the Consumer Electronics opportunity will now be much more weighted to the second half, to reflect product launch cycles. Extending existing business and capturing value-added business in our markets beyond 2016, including across the whole of Consumer Electronics, remains our focus.

David Hummel, Chief Executive of Victrex, said: "Whilst we expect the softness in Q1 to continue through the first half year, our latest view for the second half, including Consumer Electronics being much more weighted to the second half, points towards a stronger performance, compared to the second half of 2015.

"These assumptions mean we are comfortable with current expectations for the full year.

"Looking further ahead, our medium to longer term portfolio remains attractive, alongside our focused strategy of moving further downstream and an increasingly value-added proposition."

Victrex retains a strong financial position, with no significant changes since 30 September 2015.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 7809 595831

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Teneo Strategy:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

 

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 08.30am. Please contact Laura Stewart at Teneo Strategy for details on +44 (0) 203 603 5220 or laura.stewart@teneostrategy.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFETFVIAIIR
Date   Source Headline
1st Dec 201712:51 pmRNSBlock listing Interim Review
30th Nov 20171:41 pmRNSTotal Voting Rights
27th Nov 201711:20 amRNSAdditional Listing
17th Nov 20173:57 pmRNSDirector/PDMR Shareholding
31st Oct 20179:41 amRNSTotal Voting Rights
17th Oct 20173:29 pmRNSDirector/PDMR Shareholding
29th Sep 201710:31 amRNSTotal Voting Rights
19th Sep 20172:59 pmRNSDirector/PDMR Shareholding
4th Sep 20177:01 amRNSCEO-designate update
4th Sep 20177:00 amRNSReduction in effective tax rate
31st Aug 20173:31 pmRNSTotal Voting Rights
17th Aug 201711:39 amRNSDirector/PDMR Shareholding
31st Jul 201710:36 amRNSTotal Voting Rights
25th Jul 20177:00 amRNSTrading Statement
18th Jul 20172:10 pmRNSDirector/PDMR Shareholding
30th Jun 20172:09 pmRNSTotal Voting Rights
19th Jun 20174:18 pmRNSDirector/PDMR Shareholding
1st Jun 20179:51 amRNSBlock listing Interim Review
31st May 20179:22 amRNSTotal Voting Rights
31st May 20179:05 amRNSHolding(s) in Company
19th May 20179:39 amRNSAdditional Listing
18th May 201710:23 amRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
28th Apr 20172:39 pmRNSTotal Voting Rights
19th Apr 20172:17 pmRNSDirector/PDMR Shareholding
19th Apr 20177:57 amRNSDirectorate Change
6th Apr 20177:00 amRNSAcquisition
31st Mar 201710:32 amRNSTotal Voting Rights
28th Mar 20177:00 amRNSCapital Markets Day
24th Mar 20172:44 pmRNSHolding(s) in Company
17th Mar 20172:12 pmRNSDirector/PDMR Shareholding
17th Mar 20179:34 amRNSHolding(s) in Company
14th Mar 201710:56 amRNSHolding(s) in Company
9th Mar 20174:33 pmRNSHolding(s) in Company
28th Feb 201710:49 amRNSTotal Voting Rights
17th Feb 201711:30 amRNSDirector/PDMR Shareholding
8th Feb 20171:59 pmRNSResult of AGM
8th Feb 20179:00 amRNSAudit Tender Notification
8th Feb 20177:00 amRNSAGM Statement
31st Jan 20173:54 pmRNSTotal Voting Rights
17th Jan 20172:52 pmRNSDirector/PDMR Shareholding
5th Jan 201711:31 amRNSAnnual Financial Report
30th Dec 201611:37 amRNSHolding(s) in Company
30th Dec 201610:00 amRNSTotal Voting Rights
21st Dec 20169:14 amRNSDirector Declaration
19th Dec 201612:54 pmRNSDirector/PDMR Shareholding
15th Dec 20169:02 amRNSDirector Declaration
8th Dec 20163:41 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSFinal Results
1st Dec 201611:53 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.